Article (Scientific journals)
Efficacite anti-fracturaire de l'ibandronate administre par voie intraveineuse: de la complexite des etudes epidemiologiques interventionnelles a la pratique quotidienne.
NEUPREZ, Audrey; Hiligsmann, Mickaël; Bruyère, Olivier et al.
2009In Revue Médicale de Liège, 64 (10), p. 525-9
Peer reviewed
 

Files


Full Text
Anti-fracture efficacy of intravenous ibandronate.pdf
Publisher postprint (333.94 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Numerous epidemiological approaches are used to demonstrate the efficacy of a new chemical entity. In postmenopausal osteoporosis, anti-fracture efficacy can be assessed through prospective, randomized controlled trials, meta-analyses or real-life setting studies. Intravenous ibandronate was recently marketed, with the aim of optimizing drug absorption and adherence to treatment. Furthermore, this new formulation avoids gastrointestinal side effects and constrains linked to the oral intake of the medication. Spinal anti-fracture efficacy of IV ibandronate derives from a non-inferiority bridging study, using surrogate endpoints, i.e., bone mineral density and biochemical markers of bone turnover, compared to the oral daily formulation, previously registered for the treatment of osteoporosis in Europe. Coherent results from two separate meta-analyses have suggested that the non-vertebral anti-fracture efficacy of IV ibandronate is similar to that observed with oral, daily and weekly bisphosphonates. Similarly, a recent real-life setting study, based on claims from an US database, suggests that hip fractures are reduced, with IV ibandronate, to the same extend as they are with oral bisphosphonates. Notwithstanding, those results should probably be confirmed in an European setting, before being extrapolated, in daily practice, to the Belgian population.
Disciplines :
General & internal medicine
Author, co-author :
NEUPREZ, Audrey ;  Université de Liège - ULiège > Département des Sciences de la Santé Publique > Epidémiologie, Santé Publique et Economie de la Santé
Hiligsmann, Mickaël ;  Université de Liège - ULiège > HEC-Ecole de gestion : UER > Economie industrielle
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
French
Title :
Efficacite anti-fracturaire de l'ibandronate administre par voie intraveineuse: de la complexite des etudes epidemiologiques interventionnelles a la pratique quotidienne.
Alternative titles :
[en] Anti-fracture efficacy of intravenous ibandronate: how to translate epidemiological studies into daily clinical practice
Publication date :
2009
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Hopital de Baviere, Liège, Belgium
Volume :
64
Issue :
10
Pages :
525-9
Peer reviewed :
Peer reviewed
Available on ORBi :
since 25 November 2009

Statistics


Number of views
67 (5 by ULiège)
Number of downloads
86 (3 by ULiège)

Bibliography


Similar publications



Contact ORBi